Important Notice - Confidentiality  

This message and its attachments contain confidential information intended only for the perusal of the recipient and is provided pursuant to the terms stated herein. The confidential information comprises of this email and its attachments, links, business plans, communications, disclosures (written and oral) and other materials ("Confidential Information") as provided now or at any time in future by Daniel Trenton or Lifecycle Oncology  (collectively referred to as “the Group”), and is provided for the exclusive benefit of the Group to facilitate its business objectives.  Upon receiving, reading, accessing, opening links, downloading, or viewing the contents of this email (and any links or attachments) you agree that the Confidential Information is confidential in nature, that you receive the Confidential Information as fiduciary to the Group and that you will not attempt to use the Confidential Information for any alternative purpose other than to consider making an offer for investment or to collaborate with the Group or as otherwise expressly authorised by the Group in writing from time to time. You understand and agree that you may not, use, disseminate, publish, distribute, reproduce, forward, share or display this information with any other parties without the express written authorisation of the Group and that the Group may take injunctive action, seek equitable remedies and other damages (without election limiting other legal rights available to the Group) as the Group )(or any individual entity of the Group) determines appropriate.  If you are not the intended recipient of this message you are hereby notified and understand that the information is confidential and that any use, dissemination, distribution or reproduction of this message and any links or attachments is strictly prohibited. If you have received this message in error please contact the sender immediately. If you do not agree with these terms, you must inform the Group that you do not accept these terms in writing via email within 5 days of receipt of the Confidential Information and must not examine, view, share, publish, display, reproduce, disseminate or read the Confidential Information.

To access the Confidential Information in agreement with the above terms, you may access by clicking below:

www.lifecycletech.com.au/docs